Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Amicus Therapeutics
ClinicalTrials.gov Identifier:
NCT00925301
First received: June 19, 2009
Last updated: March 31, 2016
Last verified: March 2016